FRAMINGHAM, Mass. November 30, 2023 (PRNewswire) – Variantyx, a leader in genomic precision medicine, today announced that the set of...

FRAMINGHAM, Mass. November 10, 2023 (PRNewswire) – Variantyx, a leader in genomic precision medicine, today announced the launch of its...

FRAMINGHAM, Mass. October 18, 2023 (PRNewswire) – Variantyx, a leader in genomic precision medicine today, announced that it has secured...

Somatic testing of solid tumors has become the standard of care. Specific mutations in genes such as BRAF, EGFR, NTRK...

Meet Greice, Associate Director of Germline Assay Development at Variantyx! This inspired me to get an MS and PhD in...

Just 13 days ago, June 22nd to be exact, the American College of Medical Genetics and Genomics (ACMG) published the...

Meet Daniel Avinoam, Laboratory Operations Automation Specialist at Variantyx! Shortly after joining I was promoted to the operations team, where...

Today we officially welcomed two new Illumina Novaseq XPlus sequencers with a company-wide ribbon cutting ceremony. We can’t wait to complete validation (already under way!)…

Funding Round is Led by New Era Capital Partners and Includes Peregrine Ventures, Robert Bosch Venture Capital, 20/20 HealthCare Partners,...

Genomeweb | May 11, 2021 Variantyx, a genetic testing company offering clinical whole-genome sequencing-based assays, is expanding its menu to...